@article{JTD2117,
author = {Joe Y. Chang and Dirk De Ruysscher},
title = {Individualized hypo/hyperfractionated radiotherapy for non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {6},
number = {4},
year = {2014},
keywords = {},
abstract = {Radical radiotherapy has a crucial role in the management of non-small cell lung cancer (NSCLC). Stereotactic ablative radiotherapy [SABR, also known as stereotactic body radiotherapy (SBRT)], which involves the administration of biologically effective doses (BEDs) in excess of 100 Gy in a few large radiation doses in a short overall treatment time, for stage I NSCLC has produced local control rates in excess of 90% and survival comparable to that after lobectomy.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/2117}
}